€1.84 billionTotal budget of Global Health EDCTP3
€597 millionFunding for 116 projects with clinical trials and scientific studies
€109 millionFunding for 38 projects that strengthen clinical research capacity in sub-Saharan Africa
49 members of EDCTP Association33 African and 16 European countries
508 participating entitiesfrom 69 countries
33 SMEsparticipating in projects
Our projects
Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...
Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.
Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.
Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...
Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).
TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...
Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.
Antibiotic-based combination therapy for severe malaria and bacterial bloodstream infectionsThe FACT project is developing an innovative treatment that targets both severe malaria and...
Our community speaks
‘My message to any young researcher that's considering applying to EDCTP is: do it!’Catherine Hankins, Senior Fellow at the Amsterdam Institute for Global Health & Development
‘This programme facilitates collaboration between North and South and invests in innovation and development of the next generation.’John Gyapong, Vice-chairperson of the Global Health EDCTP3 Scientific Committee
‘Global Health EDCTP3 is unique in addressing the gaps: strengthening the capacity and the innovation components that are essential for the developing countries.’Eleni Aklilu, Professor of Tropical Pharmacology
